meta-Hydroxynorephedrine
meta-Hydroxynorephedrine or 3-hydroxynorephedrine, also known as 3,β-dihydroxyamphetamine, is an adrenergic drug of the amphetamine class which was patented as a vasopressor and nasal decongestant but was never marketed.[1][2] It is the racemic form of the sympathomimetic drug metaraminol.
![]() | |
| Clinical data | |
|---|---|
| Other names | m-hydroxypropadrine m-hydroxyphenylpropanolamine α-methyl-m-octopamine 3,β-dihydroxyamphetamine 3,β-dihydroxy-α-methylphenethylamine |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C9H13NO2 |
| Molar mass | 167.208 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
See also
- Hydroxynorephedrine
- Metaraminol
- Gepefrine
- Phenylpropanolamine
References
- F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 106. ISBN 978-0-412-46630-4. Retrieved 24 April 2012.
- Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. p. 2110. ISBN 978-0-8155-1526-5. Retrieved 24 April 2012.
Cardiac stimulants excluding cardiac glycosides (C01C) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adrenergic and dopaminergic agents |
| ||||||||||||||
| Phosphodiesterase inhibitors (PDE3I) | |||||||||||||||
| Other cardiac stimulants |
| ||||||||||||||
| |||||||||||||||
Decongestants and other nasal preparations (R01) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Topical |
| ||||||||||
| Systemic use: Sympathomimetics |
| ||||||||||
| |||||||||||
Adrenergic receptor modulators | |
|---|---|
| α1 |
|
| α2 |
|
| β |
|
| See also |
|
Phenethylamines | |
|---|---|
| Phenethylamines |
|
| Amphetamines |
|
| Phentermines |
|
| Cathinones |
|
| Phenylisobutylamines |
|
| Phenylalkylpyrrolidines |
|
| Catecholamines (and close relatives) |
|
| Miscellaneous |
|
